Corticobasal degeneration (CBD): treatment
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Corticobasal degeneration (CBD): treatment. Levodopa/carbidopa therapeutic trial is started at 62.5mg tid. Fully referenced neurology checklist.
Levodopa
- Levodopa/carbidopa therapeutic trial is started at 62.5mg tid
- The dose is increased to 125mg tid
- 1g daily dose is needed for adequate trial
Treatments of myoclonus
Locked: subscribe to see this section.
Treatments of cognitive impairment
Locked: subscribe to see this section.
Treatments of depression and OCD
Locked: subscribe to see this section.
Other treatments
Locked: subscribe to see this section.
References
- Armstrong MJ. Diagnosis and treatment of corticobasal degeneration. Curr Treat Options Neurol 2014; 16:282.
- Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47:1-9.
